首批入选！万孚生物血栓四项被纳入创新药械产品目录

Core Viewpoint - The Guangzhou Municipal Bureau of Industry and Information Technology has released the first batch of the "Guangzhou Innovative Drug and Medical Device Product Catalog," which aims to significantly reduce the medication burden on patients by covering major disease areas such as tumors, immunity, and cardiovascular diseases [1] Company Summary - Wanfu Biological's thrombus early screening project, which is the first in China to receive certification for market launch, has had its four testing reagents (TAT/PIC/TM/t-PAIC) included in the catalog, supporting early diagnosis and treatment of thrombus and hemostatic diseases [1]